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STUDIES ON THE ETIOLOGY OF UROLITHIASIS ：
EFFECTS OF VITAMIN B， AND VITAMIN B， ON
      URINARY OXALATE EXCRETION
’Sunao YAcHiKv， ’sadashi OHKAwA， Masafumi TAKEucHi and TakaQ SoNoDA
From the DePartment of Urology， Osaha University Medical School
         ．．（Chdirman’Pπゾ．71． Sonoda，肱D．）
   Oxqlic acid rr｝etabolism is of． considerable importance， because approximately 70％ of hyman
urinary stoneS are compQsed of either pure calcium oxalate or calcium oxalate plus apatite． ， It
．is well know阜that．vitarlin B6 affects oxalic acid metabolisエn勿vivo and vitamin BI does it in
vitro． However， the effect of vitarnin Bi on urinary oxalate excretion has not been established
yet． ln this paper， the influence of vltamin Bi deficiency on urinary oxalate excretion in rats
was studied and was compared with the change in．vitamin B6 deficjency and i．n both vitamin
B6 and Bi deficiency． The oxalic’≠モ奄?in urine was estirnated by Zarembski and Hodgkinson’s
method．
   In vitarriin Bi deficient rats， the increase of urinary oxalate exZ retion was ’proVed． How－
ever， the jncrease was moderate ． in comparison with the marked increase of urinary oxalate
excretion・in vitamin B6 deficient rats． There was no difference between ・the increase in vitarnin
B6 deficient rats and the increase in both vitamin B6 and Bi deficient rats．
   Patients with oxalate－containing urinary stone excreted approxim’ately ’normal amounts of
oxalate except several cases with increased urinary oxalate ekcretion． ln theSe stone patients
with increased tirinary oxalate excretion， vitamin B6 and vitamin Bi administration reduced the
urinary oxalate excretion． ・
  ・Fropa these results， it iS suggested that vitamin B6’ and Bi PlqY，a significan’t role in oxalate
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Fig． 1 Urinary excretion of oxalic acid in
 controls and vitamin B6 deficient rats． The
 points and vertical lines represent mean













































VitaminB6 g Bl （‘’）
Contro1
299
   o     O  l  2  3  4  5
     丁ime on．yitamin Bl de「icient diet（weeks）
Fig．2 Urinary excretion of oxalic aciq in
 controls and vitamin Bi deficient rats． The
 points and vertical lines represent mean
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耳ig．3 Changes．of pyruvic acid in blood of
 rats during the period of vitamin Bi de－
 ficiency． The points and vertical lines re－
 present mean values and standard deviation
 from 10 rats． ．
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Fig． 4 Urinary ’excretion’of oxalic acid in
 ¢ontrols and vitamin B6 and Bi deficient rats．
 The． pointS qnd vertical ！ines represent mean
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Fig． 5 Urinary oxalate excretion in urinary
 stone patients and in normal control subjects．
 In each group， solid lines represent mean
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Fig． 6 Effect of’vitamin Bi and B6 administra－
 ti．on on urinary oxalate excretion in urinary
 stone patients． Zone represents standard
 deviation of norrnal control subjects．
Table 1 Effect of vitamin B6 and Bi administra－











Table 2 Effect of low oxalate diet on urinary
 oxalate excretion in urinary stone patients．
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Fig． 7 ’Major pathways in glyoxylate metabo－
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Fig． 8 Pathways of L－ascorbic qcid metabo－
















Gershoff and Faragalla（1959） が報告し4），
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